Summary
In 50 patients without renal insufficiency, fibrinolytic activity, as reflected by euglobulin lysis time, was determined in blood obtained from the renal veins, the renal artery and a peripheral vein. Fibrinolytic activity was found to be significantly higher in the renal veins than in the renal artery and the peripheral vein. Other coagulation and fibrinolysis parameters did not show such differences. In addition, a patient with acute oligoanuric renal failure was investigated. This patient demonstrated reduced overall fibrinolytic activity, but there were no differences between the activity in the blood of the renal veins and that of the renal artery or peripheral vein. It seems, therefore, that the kidneys release plasminogen activators into the systemic circulation. This may be decreased in renal failure, probably contributing to the well-known diminished fibrinolysis in some kidney diseases.
Similar content being viewed by others
References
Andrassy K, Buchholz L, Bleyl U, Ritz E, Seidel D (1976) Topography of human urokinase activity in renal tissue. Nephron 16:213–219
Buluk K, Furman M (1962) On the controlling function of the kidneys in fibrinolysis. Experientia 18:146
Canavese C, Stratta P, Pacitti A, Mangiarolti G, Racca M, Oneglio R, Vercellone A (1982) Impaired fibrinolysis in uremia: partial and variable correction by four different dialysis regimes. Clin Nephrol 17:82–89
Dooijewaard G, van Tersel JJL, Los P, Kluft C (1983) The intrinsic system of fibrinolysis: identification and partial purification of plasma urokinase. In: Davidson JF, Bachmann F, Bouvier CA, Kruithof EO (eds) Progress in fibrinolysis, vol. VI, Churchill Livingstone, Edinburgh London Melbourne New York, pp 46–49
Hedner K, Nilsson IM (1971) Urokinase inhibitors in serum in a clinical series. Acta Med Scand 189:185–189
Highsmith RF, Kline DL (1971) Kidney: primary source of plasminogen after acute depletion in the cat. Science 174:141–142
Highsmith RF, Kline DL (1973) Plasminogen restoration by the kidney mediated by a plasma factor. Am J Pathol 225:1032–1037
Isacson S, Nilsson IM (1969) the kidneys and the fibrinolytic activity in the blood. Thromb Diath Haemorrh 22:211–215
Kucinsky CS, Fletcher AP, Sherry S (1968) Effect of urokinase antiserum on plasminogen activators: demonstration of immunologic dissimilarity between plasma plasminogen activator and urokinase. J Clin Invest 47:1238–1253
Lijnen HR, Collen D (1981) Biochemical principles of fibrinolytic therapy. In: Trübestein G (ed) Urokinase therapy. Schattauer, Stuttgart, pp 7–20
MacFarlane RG, Pilling J (1947) Fibrinolytic activity of normal urine. Nature 159:779
McKay DG (1973) Blood coagulation and renal disease. Perspect Nephrol Hypertens 2:171–207
Miles AL, Rothschild Z, Griffin JH (1981) Dextran sulfate stimulated fibrinolytic activity in whole human plasma: dependence on the contact activation system and on a urokinase related antigen. Thromb Haemost 46:211
Niewiarowski K, Furman M (1962) On the controlling function of the kidneys in fibrinolysis. Experientia 18:146–147
Sanchez-Ibarrola A, Qazzaz S, Naish P (1981) Clearance of fibrin form glomeruli. Renal cortical fibrinolytic response after thromboplastin infusion in the rat. Clin Sci 60:47–53
Schrader J, Kramer P, Züchner C, Scheler F (1983) Niere und Fibrinolyse — Untersuchungen im menschlichen Nierenvenenblut. Nieren-Hochdruck 12:348
Shakespeare M, Wolf P (1979) The demonstration of urokinase antigen in whole blood. Thromb Res 14:825–835
Sraer JD, Sraer J, Ardaillou R, Richet G (1981) The glomerulus: site of synthesis and target for hormones and chemical mediators. Adv Nephrol 10:293–314
Wijngaards G, Kluft C, Groeneveld E (1982) Demonstration of urokinase-related fibrinolytic activity in human plasma. Br J Haematol 51:165–169
Wun T-C, Schleuning W-D, Reid E (1982) Isolation and characterization of urokinase from human plasma. J Biol Chem 257:3276–3283
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Schrader, J., Neuhaus, K.L., Tebbe, U. et al. Fibrinolytic activity in renal venous blood in man. Klin Wochenschr 64, 587–589 (1986). https://doi.org/10.1007/BF01735260
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01735260